Literature DB >> 9358557

Chitosan and chitosan/ethylene oxide-propylene oxide block copolymer nanoparticles as novel carriers for proteins and vaccines.

P Calvo1, C Remuñan-López, J L Vila-Jato, M J Alonso.   

Abstract

PURPOSE: The aim of this study was to investigate the interaction between the components of novel chitosan (CS) and CS/ethylene oxide-propylene oxide block copolymer (PEO-PPO) nanoparticles and to evaluate their potential for the association and controlled release of proteins and vaccines.
METHODS: The presence of PEO-PPO on the surface of the nanoparticles and its interaction with the CS was identified by X-ray photoelectron spectroscopy (XPS). The mechanism of protein association was elucidated using several proteins, bovine serum albumin (BSA), and tetanus and diphtheria toxoids, and varying the formulation conditions (different pH values and concentrations of PEO-PPO), and the stage of protein incorporation into the nanoparticles formation medium.
RESULTS: BSA and tetanus and diphtheria toxoids were highly associated with CS nanoparticles partly due to electrostatic interactions between the carboxyl groups of the protein and the amine groups of CS. PEO-PPO also interacted electrostatically with CS, thus competing with the proteins for association with CS nanoparticles. A visible amount of PEO-PPO was projected towards the outer phase of the nanoparticles. Proteins were released from the nanoparticles at an almost constant rate, the intensity of which was closely related to the protein loading. Furthermore, the tetanus vaccine was released in the active form for at least 15 days.
CONCLUSIONS: CS and CS/PEO-PPO nanoparticles prepared by a very mild ionic crosslinking technique are novel and suitable systems for the entrapment and controlled release of proteins and vaccines.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9358557     DOI: 10.1023/a:1012128907225

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  8 in total

Review 1.  Transmembrane transport of peptide type compounds: prospects for oral delivery.

Authors:  E Lipka; J Crison; G L Amidon
Journal:  J Control Release       Date:  1996-05       Impact factor: 9.776

Review 2.  Mucosal penetration enhancers for facilitation of peptide and protein drug absorption.

Authors:  V H Lee; A Yamamoto; U B Kompella
Journal:  Crit Rev Ther Drug Carrier Syst       Date:  1991       Impact factor: 4.889

3.  Pulmonary delivery of salmon calcitonin dry powders containing absorption enhancers in rats.

Authors:  S Kobayashi; S Kondo; K Juni
Journal:  Pharm Res       Date:  1996-01       Impact factor: 4.200

Review 4.  Alternative delivery systems for peptides and proteins as drugs.

Authors:  D A Eppstein; J P Longenecker
Journal:  Crit Rev Ther Drug Carrier Syst       Date:  1988       Impact factor: 4.889

5.  Chitosan as a novel nasal delivery system for peptide drugs.

Authors:  L Illum; N F Farraj; S S Davis
Journal:  Pharm Res       Date:  1994-08       Impact factor: 4.200

6.  Adsorption of BSA on strongly basic chitosan: Equilibria.

Authors:  H Yoshida; H Nishihara; T Kataoka
Journal:  Biotechnol Bioeng       Date:  1994-05       Impact factor: 4.530

7.  Spherical agglomerates of water-insoluble drugs.

Authors:  R Bodmeier; O Paeratakul
Journal:  J Pharm Sci       Date:  1989-11       Impact factor: 3.534

8.  A novel approach to the oral delivery of micro- or nanoparticles.

Authors:  R Bodmeier; H G Chen; O Paeratakul
Journal:  Pharm Res       Date:  1989-05       Impact factor: 4.200

  8 in total
  90 in total

1.  Comparison of diafiltration and tangential flow filtration for purification of nanoparticle suspensions.

Authors:  Gautam Dalwadi; Heather A E Benson; Yan Chen
Journal:  Pharm Res       Date:  2005-12       Impact factor: 4.200

2.  Studies on effect of pH on cross-linking of chitosan with sodium tripolyphosphate: a technical note.

Authors:  Devika R Bhumkar; Varsha B Pokharkar
Journal:  AAPS PharmSciTech       Date:  2006-06-02       Impact factor: 3.246

Review 3.  Methods for the preparation and manufacture of polymeric nanoparticles.

Authors:  Christine Vauthier; Kawthar Bouchemal
Journal:  Pharm Res       Date:  2008-12-24       Impact factor: 4.200

4.  Biocompatible medical implant materials with binding sites for a biodegradable drug-delivery system.

Authors:  Haifa Al-Dubai; Gisela Pittner; Fritz Pittner; Franz Gabor
Journal:  Nanotechnol Sci Appl       Date:  2011-10-03

Review 5.  Design opportunities for actively targeted nanoparticle vaccines.

Authors:  Tarek M Fahmy; Stacey L Demento; Michael J Caplan; Ira Mellman; W Mark Saltzman
Journal:  Nanomedicine (Lond)       Date:  2008-06       Impact factor: 5.307

Review 6.  Chitosan and its use as a pharmaceutical excipient.

Authors:  L Illum
Journal:  Pharm Res       Date:  1998-09       Impact factor: 4.200

7.  Chitosan-zinc-insulin complex incorporated thermosensitive polymer for controlled delivery of basal insulin in vivo.

Authors:  Mayura Oak; Jagdish Singh
Journal:  J Control Release       Date:  2012-08-07       Impact factor: 9.776

Review 8.  Nanoparticle-based targeted drug delivery.

Authors:  Rajesh Singh; James W Lillard
Journal:  Exp Mol Pathol       Date:  2009-01-07       Impact factor: 3.362

Review 9.  Overview of the main methods used to combine proteins with nanosystems: absorption, bioconjugation, and encapsulation.

Authors:  Mariagrazia Di Marco; Shaharum Shamsuddin; Khairunisak Abdul Razak; Azlan Abdul Aziz; Corinne Devaux; Elsa Borghi; Laurent Levy; Claudia Sadun
Journal:  Int J Nanomedicine       Date:  2010-02-02

10.  Nanovaccine for leishmaniasis: preparation of chitosan nanoparticles containing Leishmania superoxide dismutase and evaluation of its immunogenicity in BALB/c mice.

Authors:  Mohammad Ali Danesh-Bahreini; Javad Shokri; Afshin Samiei; Eskandar Kamali-Sarvestani; Mohammad Barzegar-Jalali; Soliman Mohammadi-Samani
Journal:  Int J Nanomedicine       Date:  2011-04-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.